A study by U.S. scientists shows the benefits it holds the cord blood with regard to their use in the treatment of childhood leukemia. Statistically, there is a greater survival rate in children who have been treated with stem cells from umbilical cord blood than with other treatments.
The study took data from 785 children under 16 years with acute lymphoblastic leukemia or acute myeloid leukemia who formed two groups, those treated with stem cells from umbilical cord blood and those who received a bone marrow transplant. The data left no doubt, to a 20% increase in survival was reflected in the group using umbilical cord blood.
A special feature is that this blood has the potential to be used without the need for an affinity between donor and recipient, bone marrow transplantation is necessary to have full compatibility. In addition, being able to store it makes it especially interesting and important.
No comments:
Post a Comment